Cure8 research brief
The study identifies MrgprD on colonic macrophages as a driver of pro-inflammatory macrophage polarization and worse acute colitis in mice, highlighting a potential new pathway relevant to human IBD.
Researchers in IBD immunology and macrophage biology; translational scientists exploring new drug targets; clinicians following mechanistic advances in IBD.
The paper reports that global knockout of Mrgprd reduced severity of DSS-induced acute colitis in mice, with less macrophage infiltration, lower M1 polarization, preserved colon length, better barrier integrity, and reduced NF-κB activation.
Myeloid-specific deletion produced stronger protection than neuronal deletion, suggesting the effect is driven mainly by macrophages. In vitro, activating MrgprD on bone marrow–derived macrophages increased M1 responses, and bioinformatic analyses link the MRGPRD–NF-κB axis to human IBD datasets.
The findings are preclinical: the experiments were done in mice (DSS colitis model) and in cultured macrophages, with supportive computational analysis of human data. This suggests a possible target but does not establish safety or efficacy in people.
Findings are from mouse DSS-colitis experiments, in vitro macrophage work, and bioinformatic links to human data; translational relevance requires further validation.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: National Natural Science Foundation of China - 32571377; National Natural Science Foundation of China - 31870131; Natural Science Research of Jiangsu Higher Education Institutions of China - 20KJA180001; Priority Academic Program Development of Jiangsu Higher Education Institutions
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study suggests a new macrophage-linked mechanism (NINJ2 → ZBP1 → PANoptosis) that may drive intestinal inflammation in IBD and could become a target for future therapies or biomarkers.
The study identifies macrophage-derived microvesicles as modulators of intestinal barrier function and ER stress in ulcerative colitis models, suggesting a new mechanism that could be relevant to mucosal healing...
The work links a PD risk gene (LRRK2 G2019S) to increased intestinal NET formation and enteric α-synuclein in mouse colitis, suggesting a neutrophil-mediated inflammatory route by which gut inflammation and microbiota...
